A study that investigated the potential of the compound PRM-151 for reducing progressive bone marrow fibrosis in patients with advanced myelofibrosis has shown initial positive results. Myelofibrosis is a life-threatening bone marrow cancer.
http://ift.tt/1IsxT2D
http://ift.tt/1IsxT2D
No comments:
Post a Comment